¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10
±³À°ÀÏÀÚ : 2019-05-10
±³À°Àå¼Ò : °æÁÖ È­¹éÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : ´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ-ȸ¿ø 130,000¿ø/ºñȸ¿ø 200,000¿ø »çÀüµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 70,000¿ø/ºñȸ¿ø 90,000¿ø ÇöÀåµî·Ï: Àü¹®ÀÇ-ȸ¿ø 200,000¿ø/ºñȸ¿ø 250,000¿ø ÇöÀåµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 90,000¿ø/ºñȸ¿ø 110,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:00~09:25 Overview: understanding the relationship between ¥â Cell dynamics and diabetes  °­½Å¾Ö(¿¬¼¼ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:25~09:50 GLP1 increases b cell regeneration by promoting a to b treansdifferentiation  ÀüÈñ¼÷(°¡ÃµÀÇ´ë ¾Ï´ç´¢¿¬±¸¿ø) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:50~10:15 Dynamic pathology of islet endocrine cells in diabetes  ¿ø±ÔÀå(¿µ³²ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 10:15~10:40 SREBP1c-PAX4 Axis in ¥â cell compensation  ±èÀç¹ü(¼­¿ï´ë »ý¸í°úÇкÎ) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1,2 11:30~12:10 Bring the spotlight onto a niche in diabetes research  ±èÀÎÁÖ(ºÎ»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room5 12:30~13:10 Managing diabetes in elderly: go easy and individualizes  ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:10~14:35 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of cardiologist  Á¶Áø¸¸(°æÈñÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:35~15:00 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of endocrinologist  ¼­¼ºÈ¯(µ¿¾ÆÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:00~15:25 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - pro  ¹Úö¿µ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:25~15:50 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - cons  ¹®¹Î°æ(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:10~16:35 Urinary EV miRNA in the prediction of DKD progression  ÀÌ´ëÈ£(°¡ÃµÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:35~17:00 RNA sequence tramscriptome in DKD  ¹Ú¹Ì¿µ(ºÎ»ê´ë ÀÇ»ý¸í¿¬±¸¿ø) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:00~17:25 Role of ACE2 in diabetic kidney disease  ¹èÀºÈñ(Àü³²ÀÇ´ë ½ÅÀå³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:25~17:50 Basic research in degenerative eye disease in diabetes  ¹ÚÅ°ü(¼øõÇâÀÇ´ë ¾È°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2019 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ(¾È°úºÐ¾ßÀÇ ÀΰøÁö´É) : 2019-05-10
´ÙÀ½±Û ±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»ç Áý´ãȸ(°æºÎÀÓÆļ±¿°) : 2019-05-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
330 ÃæºÏ ´ëÇѼҾưúÇÐȸ ÃæºÏ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2018-09-01 0 600 2018-08-08
329 ÀüºÏ Á¦20ȸ ¿µÈ£³²³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2018-09-01 0 654 2018-08-08
328 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¿¬¼¼º´¸® ½ÉÆ÷Áö¿ò : 2018-09-01 0 642 2018-08-08
327 ¼­¿ï ¼øõÇâ´ëÇб³ ¼­¿ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2018-08-31 0 894 2018-08-08
326 ¼­¿ï Á¦ 4ȸ ´ëÇÑÇǺÎÁø±ÕÇÐȸ ¿¬¼ö±³À° : 2018-08-31 0 514 2018-08-08
325 ÀüºÏ Á¦20ȸ ¿µÈ£³²³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2018-08-31 0 1,189 2018-08-08
324 ´ë±¸ ´ë±¸°æºÏ°³¿ø³»°úÀÇ»çȸ ¿¬¼ö°­Á : 2018-08-28 0 1,017 2018-08-08
323 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÒ¸éÁõ ÀÎÁöÇൿġ·á : 2018-08-26 0 1,646 2018-08-08
322 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø Á¦ 23ȸ °¡Å縯 ¾È°ú Çмú ½ÉÆ÷Áö¾ö : 2018-08-26 0 1,624 2018-08-08
321 ¼­¿ï ´ëÇÑ°³¿øÀÇÇùÀÇȸ 2018³âµµ Á¦2Â÷ ȸ¿ø¿¬¼ö±³À° : 2018-08-26 0 4,033 2018-08-08
320 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part3, 2ÀÏÂ÷) : 2018-08-26 0 888 2018-08-08
319 ¼­¿ï °í·Á´ëÇб³¾È»êº´¿ø Á¦14ȸ °í·ÁÀÇ´ë ÇǺΰúÇб³½Ç ½ÉÆ÷Áö¾ö ¹× ¿öÅ©¼ó : 2018-08-26 0 705 2018-08-08
318 ´ë±¸ 2018³â Á¦1ȸ ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ ¿¬¼ö°­Á : 2018-08-25 0 879 2018-08-08
317 ´ëÀü 2018 ´ëÇÑ¿Ü°ú¼ú±â¿¬±¸È¸ Ãß°è ½ÉÆ÷Áö¾ö ¹× Æ©ÅÍ ¿öÅ©¼ó : 2018-08-25 0 418 2018-08-08
316 Ãæ³² Àü³²´ëÇб³º´¿ø 2018 Á¦ 20Â÷ ºû°íÀ»½½°üÀý¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-08-25 0 723 2018-08-08
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷